Olink

Olink®
Part of Thermo Fisher Scientific

Peripheral rotavirus-specific T-cell responses following monovalent oral rotavirus vaccine in infants

npj Vaccines, 2026

Nicols A., Lee Y., Congrave-Wilson Z., Kim M., Cheng W., Jumarang J., Navarro J., Navarro R., Rodriguez-Angeles Y., Durand D., Taylor Z., De León R., Ochoa T., Sette A., da Silva Antunes R., Pannaraj P.

Disease areaApplication areaSample typeProducts
Infectious Diseases
Pathophysiology
Serum
Olink Target 48

Olink Target 48

Abstract

Despite evidence of varying vaccine effectiveness, T cell responses to rotavirus (RV) vaccines remain incompletely studied. To address this research gap, RV-specific T cells in the blood of infants pre- and post-monovalent RV vaccination (RV1) were analyzed for memory recall and functionality using RV-specific peptide pool stimulation. We find that RV vaccine elicits heterogenous responses with respect to cellular and humoral immunity. T cell responses to RV vaccine are detectable in the periphery, though poorly functional. Vaccination induces Th2-biased conventional effector memory and central memory CD4 + T cells, as suggested by chemokine receptor profiles, though the response wanes by 8 months post vaccination. The presence of preexisting immunity results in no significant increase in either RV-specific IgA or T cells after vaccination. Our data provides the first in-depth assessment of RV-specific T cell responses induced by vaccine, demonstrating patterns of negative and positive association with response that may play a role in protection against rotavirus disease.

Read publication ↗